Single therapy approaches are usually insufficient to treat certain diseases, due to genetic differences between patients or disease resistance. Therefore, such approaches are gradually replaced by combination therapies comprising two or more drugs. In oncology these include BRAF inhibitors, cytotoxic, anti-angiogenic or immunomodulatory agents, among others. We propose herein the use of multiresponsive nanogel composites for the co-delivery of a DNA intercalator (doxorubicin) and an anti-angiogenic and immunomodulatory agent (pomalidomide).
2 nanoparticles and explore their ability to deliver drugs upon stimulation by various triggers such as heat, light and reducing agents present in the intracellular environment. We further demonstrate that an additional polymer coating on the nanogel surface can decrease uncontrolled drug leakage, and modulate cellular uptake and the drug release profile.
INTRODUCTION
Chemotherapy still prevails as the most common treatment for cancer. However, there is a rising demand for alternative therapies, which involve the use of anticancer drugs combined with other molecularly target agents toward the reduction of side effects and the enhancement of the treatment efficacy.
1,2 The use of nanoparticles (NPs) for drug delivery is a well recognized method to control the delivery kinetics and biodistribution of the drug in question, as well as offering protection from biological conditions which can cause drug degradation. [3] [4] [5] [6] [7] Furthermore, NP materials need not be limited to one sole material or be loaded with a single drug. In fact, this leads to many possibilities in terms of triggered, controlled, drug release and co-delivery that can be combined with multimodal imaging.
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Regarding chemotherapy, NPs offer the possibility to improve treatment efficacy by delivering cytotoxic drugs to cancerous cells with minimal exposure to non-cancerous cells, thereby avoiding chemotherapy side effects. [12] [13] [14] [15] Tumors, however, are complex structures and their growth promotes angiogenesis in an autocrine manner, thereby allowing a constant supply of nutrients and oxygen to the cancerous cells. [16] [17] [18] The suppression of tumor growth by action of anti-angiogenic agents is therefore an appealing method to target cancer. 19, 20 One of the most interesting aspects therefore of NPs is their ability to deliver a combination of drugs which can target different aspects of tumour growth and persistence.
One such example of this is Doxil, a liposomal doxorubicin carrying NP system, which has been combined with dexamethasone and pomalidomide and is currently in clinical trials to treat Multiple Melanoma (MM) cancer (NCT01541332 from www.clinical trials.gov).
In this context, we propose the use of nanogels for combination therapy and controlled release of drugs. Nanogels are formed by crosslinked polymeric networks that possess a 4 large water content and open spaces with a characteristic mesh size. The mesh size governs the diffusion of drugs within the nanogel and the chemical interaction between the polymer structure determines the drug entrapment efficiency. 21, 22 Nanogels show several advantages over other drug carrier systems, which are related with the mild conditions of drug encapsulation, which allow entrapment of labile drugs (hydrophilic and hydrophobic), their excellent biocompatibility and the easy tailoring of their responsiveness toward triggers of drug release. 23, 24 In contrast, the main drawback is the uncontrolled leakage of drugs. The nanogel polymer chemistry can be designed to release cargo molecules upon different stimuli such as e.g. pH or heat. 25 By including gold (Au) NPs within the nanogel, nearinfrared (NIR) illumination can be used to induce local heating at the AuNP surface, thereby providing a further trigger for drug release and offering NP-based hyperthermia. 26, 27 Importantly, the use of NIR illumination renders such a system suitable for use in biological tissues, due to the reduced absorption by tissue of light with wavelength between 650 and 950 nm. 28 In this proof of concept work we demonstrate that AuNP-containing thermosensitive nanogels, coated with an appropriate polyelectrolyte, are suitable platforms for the codelivery of doxorubicin (Doxo) -a cytotoxic agent and DNA intercalator -and pomalidomide (Poma) -an anti-angiogenic and immunomodulatory agent. [29] [30] [31] These drug delivery systems are preferentially cytotoxic to cancer cells in vitro, while also being efficient at inhibiting angiogenesis in tube-formation assays in vitro. Nanogels are a highly versatile system in which drug release profiles can be controlled via polyelectrolyte coating and/or various external stimuli, showing good biocompatibility and biodegradation in vitro.
The final nanogels thus offer a stable platform that can be prepared by straightforward production methods and used to deliver several drugs, with both hyperthermia and photothermal ablation therapy characteristics.
RESULTS AND DISCUSSION

Formation of polyelectrolyte coated AuNP decorated PEGMA nanogels
The thermoresponsive nanogels used for the loading and co-delivery of the two selected drugs were based on poly(ethylene glycol) methyl ether methacrylate (PEGMA), and formed by the well-established free radical polymerization method. [32] [33] [34] PEGMA nanogels were chosen because of their easy-to-tailor lower critical solution temperature (LCST), ranging from room temperature up to 90 ºC, 35, 36 and because their monomer constituents are non-toxic. 37 These are two major advantages, as compared e.g. to the widely used poly(N-isopropyl acrylamide) (pNIPAM). 38, 39 In the second step of the synthesis, a surfactant-free method was used to incorporate light responsive (plasmonic) AuNPs within the PEGMA nanogels, thereby avoiding potential toxicity of surfactants and keeping the AuNPs surface free to adsorb other molecules (Figure 1a) . To this purpose, pre-made nanogels were immersed in a solution of HAuCl 4 , followed by addition of a strong reducing agent, NaBH 4 . The amino groups in the nanogels (present in the monomer 2-aminoethyl methacrylate hydrochloride) coordinate the gold precursor and small gold seeds of approximately 3 nm were formed upon NaBH 4 reduction.
These seeds were subsequently grown by addition of HAuCl 4, sodium bromide and formaldehyde, which displays a pH-dependent reducing potential. 40 Sodium bromide helped in controlling AuNP growth due to the formation of a gold bromide complex with higher stability as compared to free HAuCl 4 . When the process was carried out, in the absence of either Au seeds or sodium bromide, nanogels were obtained with particle disparity, anisotropy and aggregation ( Figure S1 , Supporting Information). On the contrary, seeded growth produced nanogels with evenly distributed AuNPs with an average size of 23.2 ± 6.1 nm and a low proportion of anisotropic particles (Figure 1b) . The nanogel containing AuNPs displayed a localized surface plasmon resonance (LSPR) band centered at 540 nm (Figure 1c) , which is redshifted with respect to free AuNPs with similar sizes due to some anisotropy and plasmon coupling between the AuNPs in the gel. This two-step process allows a good level of control over the final AuNP size, which can range from 9 to 30 nm simply by tuning the amount of Au seed-loaded nanogels added to the growth solution ( Figure S2 ). PEGMA nanogels were subsequently wrapped with biodegradable and biocompatible polyelectrolytes to modify the release profile of encapsulated drugs, and to add a coating that can easily bind other functional moieties (such as antibodies or dyes) for future applications. 41 Functionalization was carried out by immersing AuNP-loaded nanogels in the appropriate polyelectrolyte solution followed by several washing steps to remove non-adsorbed polyelectrolytes. Samples with different surface compositions were named as follows: 1) AuNG1 had no coating, 2) AuNG2 was coated with poly-L-arginine and 3) AuNG3 was coated with polyalginate. We studied the influence of the two different coatings, i.e. the polypeptide poly-L-arginine and the polysaccharide polyalginate, on the physicochemical properties of the nanogels, and their drug loading and release profiles for both Doxo and Poma. were synthesized by reduction with NaBH 4 . Further growth was realized by introducing the nanogels with seeds in a growth solution containing NaBr and formaldehyde at high pH. The obtained nanogels were finally wrapped with a layer of polyelectrolyte. b) Representative TEM pictures of the nanogels during the different growth steps, as labeled. c) UVVis spectra of the corresponding particle colloids.
Influence of polyelectrolyte coatings on the physicochemical properties of PEGMA nanogels
The presence of the polyelectrolytes on PEGMA nanogels was confirmed by X-ray photoelectron spectroscopy (XPS), zeta potential, LSPR and particle size analysis. XPS data showed a clear decrease in the amount of Au on the nanogel surface between coated and non-coated nanogels. Additionally, nitrogen was identified in sample AuNG2 due to 8 the amino groups in poly-L-arginine, whereas AuNG3 showed a higher amount of oxygen due to the hydroxyl and carboxyl groups in polyalginate, as compared with AuNG1.
Changes in zeta potential, LSPR and particle size were also observed, as shown in Table 1 .
AuNG2 was found to become more compact upon polyelectrolyte addition, which in turn reduced the AuNP interparticle distance inside the nanogels, resulting in stronger plasmon coupling and a LSPR red shift of 23 nm after functionalization (Figure 1b,c) . The decrease in overall nanogel size observed in AuNG2 is due to the strong electrostatic interaction between the negatively charged nanogel and the positively charged polyelectrolyte, which results in the formation of a polyelectrolyte-gel complex. 42 It has been reported that, if the molecular weight of the coating molecules is low enough they can even penetrate the nanogel reducing the mesh size. 43 In contrast, functionalization with the anionic polyalginate did not modify the LSPR but caused slight swelling of the nanogel, presumably due to the weaker interactions between polyalginate and the nanogel. In the context of physicochemical changes, it is worth highlighting the strong influence of polyelectrolyte coatings on the thermoresponsive behavior of PEGMA nanogels. Bare nanogels displayed a LCST above 30 ºC ( Figure S11 ) and the inclusion of AuNPs inside the nanogels did not hinder their ability to shrink or swell in response to heat changes (Figure 2a) . In contrast, we noted significant differences in the swelling ratios (Q) depending on the type of polyelectrolyte coatings. Q was defined as the ratio between the volume of the corresponding nanogel at a temperature T versus the volume at 70 ºC (Q=V(T)/V(70 ºC)). Figure 2b illustrates the observed decrease in Q for coated PEGMA nanogels. The largest decrease of Q between coated and non coated nanogels was observed for AuNG2, which almost completely lost its thermoresponsiveness. This result is in agreement with the reduction in particle size upon coating with poly-L-arginine.
Interestingly, the LCST increased from 32 ºC in AuNG1 to 36 ºC and 37 ºC for AuNG2 and AuNG3 respectively, closer to physiologically relevant temperatures. These results were confirmed with UV-Vis spectroscopy. As expected, the thermoresponsive decrease in the volume of the nanogel led to smaller inter-particle distances and hence to a red shift and broadening of the LSPR band. AuNG1 and AuNG3 behave similarly, with an approximate red shift of 14 nm between 20 and 50 ºC. We verified the reversibility of the shift by carrying out multiple heating/cooling cycles. The shift was fully reversible over 5 temperature cycles (Figure 2c, inset) . AuNG2, in contrast,
shows no change of the LSPR, in accordance with the low Q value (Q= 1.1). Interestingly, the thermoresponsive behavior of coated PEGMA nanogels was observed to further change after encapsulation of drugs, in such a way that AuNG2 recovered its thermal responsiveness (Figure 3a) . Further detailed information about the thermal behavior of different formulations of PEGMA nanogels has been included in the Supporting
Information.
In addition to the described physicochemical differences, the colloidal stability between coated and non-coated PEGMA nanogels was studied by incubating them in different media of biological interest and analyzing the corresponding values of LSPR maxima and zeta potential. 44 AuNG3 displayed higher colloidal stability in non-supplemented cell culture media as compared with AuNG1 and AuNG2, which aggregated due to the high ionic strength, as previously reported for different polymer coated AuNPs. All PEGMA nanogels showed colloidal stability in cell culture media supplemented with serum due to protein adsorption (data shown in the Supporting Information).
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Influence of polyelectrolyte coatings on stimulated drug delivery
Drug loading was achieved by immersing AuNP decorated PEGMA nanogels in an aqueous solution of drugs in basic conditions, and quantified by the decrease of drug in the loading of the nanogels, due to the presence of carbonyl and ester groups in the nanogel and amino groups in both drugs. 46 In fact, a change in the zeta potential of the nanogels toward more positive values after drug encapsulation was observed, as previously reported for similar nanogels. The mechanism of drug release triggered by heating (including NIR light irradiation) and subsequent nanogel shrinkage can be related to the removal of hydrogen bonding between the drugs and the nanogel itself, but also to the decrease in the radius of the nanogel and shortening of the diffusion path for entrapped drugs. In contrast, drugs that are released through reduced temperature induced swelling of nanogels have been shown to diffuse faster when the mesh size of the hydrogel increases due to hydrogen bonding with water molecules. 48, 49 It should be noted that, realistically, the required temperature decrease is hard to achieve in biological systems. The release mechanism of Doxo and Poma at different temperatures from AuNG2 and AuNG3 was analyzed using the semi-empirical 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 Peppas model, 50 obtaining in both cases values of the release exponent n corresponding to the anomalous transport regime (0.43<n<0.85), which represents a mixture between diffusion-controlled release and other mechanisms (see Supporting Information).
GSH was also found to enhance drug release from AuNP decorated PEGMA nanogels. This trigger is of interest for intracellular drug delivery since its concentration is over 200 fold higher within cells (0.2-10 mM) than in the extracellular environment (2-20 µM). 51, 52 To compare the GSH triggered Doxo release with that induced by heating, we exploited the ability of AuNPs to induce surface enhanced Raman scattering (SERS). SERS was used to identify Doxo within the AuNG3 nanogel after incubation with GSH, after heating and after both heating and GSH incubation, and the signals were compared to the corresponding fluorescence intensity of Doxo delivered to the supernatant from the nanogel. Figure 4b shows that both GSH and heat triggered the release of Doxo from the nanogel, and both triggers, acting in synergy, released 1.8 times more than the sum of the two triggers separately (30 min incubation time, T= 50 °C, [GSH]= 5 mM). The presence of Doxo was monitored using the characteristic SERS peak at 1420 cm -1 (corresponding to the C-O-H and C-H bending mode). The temperature increase enhanced the signal of Doxo as compared with the control experiment at room temperature, due to shortening of the interparticle distances, which is known to induce a further enhancement of the Raman signal.
However, upon application of both T increase and GSH, the Doxo signal vanished faster than by only heating. The release mechanism of GSH could be related to ion displacement, 23 since it is known that GSH adsorbs onto AuNPs and polymers and can trigger this kind of release mechanism intracellularly. 53, 54 In addition, we observed degradation and disassembly of the Au decorated PEGMA nanogels, both after GSH pH changes affect hydrogen bonding, 55 as well as charges on amino and carboxylic groups in the nanogels. As pH is also known to considerably decrease during the endocytotic pathway in cells, we studied the effect of pH on the release of Doxo from the nanogels. By exposing AuNG3 to pH 7.4 or pH 5.5, values that are representative of the extracellular and intracellular environment respectively, we noted a 2-fold increase in Doxo release.
Additionally, the increased Doxo release at low pH was more pronounced in the presence of GSH at the usual concentrations in the intracellular environment (Figure 4c) . We subsequently compared how all the aforementioned triggers can affect drug release in an environment mimicking both extracellular and intracellular conditions. Figure 4d ,e shows that intracellular conditions enhance Doxo release induced by both heat and NIR illumination. Moreover, the polyelectrolytes on the nanogels surface caused significantly different drug release profiles, AuNG2 being more efficient in avoiding drug leakage, whereas all triggers enhanced drug release from AuNG3. We therefore conclude that AuNG3 appears to release higher amounts of Doxo, yet AuNG2 releases the same drug in a more controlled way under the effect of different triggers ( Figure S14) . A similar study was carried out for the release of Poma ( Figure S14 ). In this case, release was more significantly affected at intracellular conditions (high [GSH] and low pH) than by the application of external stimuli. AuNG2 were more efficient in releasing Poma than AuNG3 and uncontrolled leakage was similar for both types of nanogels. The different release profiles shown in our work are key when selecting the appropriate carrier for a specific drug that could demand a faster release or which is very toxic and should be only released at the target cells. AuNG3, respectively. This shows significant differences in cell specificity which can indeed be ascribed to the enhanced metabolic rates of cancer cells, as well as increased levels of AuNG2 uptake compared to AuNG3, due to the overall cationic charge of the AuNG2 system. Cationic nanoparticles and also molecules with overall positive charges (e.g. cell penetrating peptides) are well known to associate with cell membranes to higher levels than their anionic counterparts. As expected, incubation of cells (both cancerous and healthy) with free Doxo resulted in rapid nuclear localization, whereas Doxo containing AuNG2 and AuNG3 were localized in endosomes (Figure 5a,b) . Similar results were obtained with breast cancer MCF-7 cells (Figure S19 ), in agreement with previous 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 studies. 56 However, such increased levels of uptake in cancer cells did not correlate with higher drug release in vitro (Figure 6 ). Figure 5 . a) Cellular uptake of free Doxo, AuNG2 and AuNG3 nanogels. A co-culture of HeLa (unstained) and HDF (blue stained) cells were exposed to Doxo and Doxo containing AuNG2 and AuNG3 for 2 h and uptake visualized using Doxo fluorescence (shown in red in main images or in white in inserts for clarity). Clear nuclear (left image) or endosomal staining (middle and right images) is seen after free or nanogel delivered Doxo, respectively. Scale bars are 100 µm. b) TEM images of HeLa cells exposed to AuNG2 and AuNG3 for 2 h and then processed the following day for TEM imaging. Magnified photos are shown in color coded boxes.
Modulation of co-delivery in vitro
The effect of the two drugs Poma and Doxo was measured separately because they affect cells through different molecular mechanisms. We first verified that the increased levels of 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 inducing any cytotoxic effects ( Figure S20) . The high levels of cytotoxicity noted in HeLa cells was slow, occurring ca. 4 days after the initial exposure of the cells to the AuNG-PEGMA nanogels. We subsequently investigated the use of NIR light as a method to improve Doxo release and subsequent cell death, compared to non-illuminated controls.
NIR-light illumination of HeLa cells incubated with AuNG-PEGMA nanogels resulted in a significant decrease in the viability over the non-illuminated cells (Figure 6b) . Non-Doxo loaded nanogels (AuNG*) were used as second control, showing that it was possible to induce hyperthermia with AuNP-PEGMA nanogels, which is interesting for combined therapy as previously reported for other drug delivery systems. 59 However, we verified that there exists an enhancement of Doxo release under NIR light illumination in vitro when lower power densities are applied, thereby avoiding hyperthermia ( Figure S21 ). 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 808 nm diode laser at 16 W/cm 2 for 20 minutes. Cell viability was measured the following day using the MTT assay (mean of triplicate wells +-SD).
The drug Poma has been shown to be highly efficient at inhibiting angiogenesis, 31 in addition to a wide variety of immune system modifying effects such as the inhibition of cytokine production in LPS-stimulated peripheral blood mononuclear cells (PBMCs), 60 thereby placing it in the group of immunomodulatory drugs (IMiDs). 61 We took advantage of these immunomodulatory effects as a method to verify that Poma remained active after release from AuNG nanogels. In order to do so, we exposed LPS-stimulated J774 murine monocyte-macrophage cells to AuNG2 and AuNG3, containing Poma alone or Doxo and Poma, and determined the levels of IL-6 cytokine produced. Compared to non-exposed controls, IL-6 levels were reduced by 90%, similar to exposure to free Poma ( Figure S22 ).
No significant differences in the ability of AuNG2 and AuNG3 to inhibit LPS-induced IL-6
were observed, nor did the presence of Doxo in the formulations hinder Poma. We next 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 stimulating conditions, the cell surface area and the aspect ratio (AR) of HUVEC cells were significantly reduced upon exposure to Poma-containing nanogels when grown under "normal" tissue culture conditions (Figure 7b,c) . IMiD compounds have been shown to activate GTPases, enzymes which are responsible for cellular cytoskeleton reorganization, cellular differentiation and movement. 62 In fibroblasts, Poma has been shown to induce formation of actin stress fibers, 62 and changes of cell area and aspect ratio have been documented upon exposure of cells to both anti-and pro-angiogenic molecules. 63, 64 Considering that the production of pro-angiogenic molecules such as VEGF and bFGF is inhibited by a cascade of signaling pathways due to pomalidomide's ability to downregulate cell adhesion molecules and reduce VEGF, bFGF and IL-6 secretion, 65 it is reasonable to assume that Poma will affect cell surface area. Exposure of HUVEC cells to Poma-containing nanogels resulted in a decrease in cell size, reducing the surface area by 1/3 -2/3 of the original value. The decrease in cell surface area and aspect ratio was more pronounced for Poma-containing AuNG2 than for AuNG3, which can be correlated with an enhanced cell uptake of these nanogels, but also with the higher degree of Poma release observed in solution. Interestingly, we did not observe any similar effects upon exposure of HUVEC cells to free Poma, which suggests that these IMiD mediated changes in cell morphology are highly dependent on exposure time and subsequent Poma release from nanogel formulations. 
CONCLUSIONS
In summary we synthesized a versatile multiresponsive drug delivery system based on thermoresponsive nanogels containing gold nanoparticles for the co-delivery of doxorubicin and pomalidomide. The gold nanoparticles inside the nanogel were synthesized in a new two-step method to ensure even particle distribution throughout the gel and surfactant-free synthesis. The leakage of drugs was reduced by wrapping the nanogels with a polyelectrolyte shell. We studied two possible coatings: polyalginate and poly-L-arginine. These two coatings produced different modifications in the thermoresponsive behavior of the nanogels and other physicochemical properties that were characterized and influenced first, the stimuli responsive release of the two drugs and 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 second, their interaction with cells and their drug delivery in vitro We showed that pH, glutathione concentration, heat and NIR-light can all trigger the release of drugs in an extent that was dependent on the chemical nature of the drug and the coating polyelectrolytes. Both coated nanogel systems showed enhanced uptake by cancer cells compared to non-cancer cells, due to their enhanced metabolism, but more specific uptake in cancer cells was seen for nanogels coated with positively charged polyalginate. Taking this into account and considering: 1) both polyelectrolyte coated PEGMA nanogels have low leakage and show a slow drug release profile, 2) the cytotoxic doxorubicin is released more efficiently by a remote controlled trigger (light) from AuNG3 than AuNG2 nanogels and 3) the release of pomalidomide was effective for the two nanogel formulations, we can conclude that polyalginate coated PEGMA nanogels can be considered as the more convenient drug delivery system for the remote controlled co-delivery of doxorubicin and pomalidomide. were all purchased from Sigma-Aldrich. Pomalidomode was purchased from Abcam. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 Alginic acid (sodium salt) was obtained from Fisher Scientific. All glassware was washed with aqua regia, rinsed 3 times with Milli-Q water and dried before use.
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Synthesis of poly ethylene glycol methacrylate nanogel.
Nanogels were synthesized by purging a 300 mL Milli-Q water solution of 5.6 g di(ethylene glycol) methyl ether methacrylate, 2,4 g poly(ethylene glycol) methyl ether methacrylate, 160 mg poly(ethylene glycol) diacrylate, 297 mg methacrylic acid and 576 mg 2-aminoethyl methacrylate hydrochloride with argon for an hour at 70 ºC. The reaction was then started by adding 120 mg of 2,2, azobis(2methylpropionamidine)dihydrochloride disolved in 2 mL of degassed Milli-Q water and run for 12 hours at 70 ºC.
Synthesis of AuNP decorated nanogel.
After washing via centrifugation, 10 mL of nanogels were incubated with 50 µL 0.1 M HAuCl 4 overnight before reduction of the gold occurs with addition of 100 µL 0.1 M NaBH 4 solution. Small gold domains of about 3-4 nm were formed and stabilized by the amino group of 2-aminoethyl methacrylate hydrochloride. The nanogels were used as seeds for the growth of bigger gold particles without further purification. Further growth of AuNP was carried out with formaldehyde under basic conditions. A 100 mL growth solution with a final concentration of 1 mM HAuCl 4 , 5 mM NaBr and different amounts of seeds was prepared followed by the addition of 500 µL formaldehyde solution (37 wt%). The reduction was finally started by changing the pH to 11 through the addition of 750 µL 1 M NaOH. The reaction was very slow due to the more stable gold-bromide complexes. After 15 minutes a color change was observed but the reaction was allowed to run overnight before particles were carefully washed via centrifugation and characterized (TEM and UVVis spectroscopy). By simply varying the amount of seeds, AuNP with different sizes were obtained. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 Loading with Doxorubicin/Pomalidomide and addition of polyelectrolyte layer Nanogels were loaded with drugs by immersing them in solutions of Doxo and/or Poma with a final concentration of 0.25 mM of each drug and a pH adjusted to ca. 8. The nanogels were incubated overnight and the addition of the polyelectrolyte layer was carried out without further purification. After mixing, the particles were gently shaken and the mixture was incubated for 30 min. Nanogels and polyelectrolytes were mixed in a 1:1 volume ratio. The solutions of polyelectrolytes were prepared with a concentration of 1 mg/mL poly alginate, 0.5M NaCl adjusted to pH=5 and 0.5 mg/mL poly-L-arginine and 0.5 M NaCl. Thereafter, nanogels were purified by centrifugation (6 times, 2240 g for 15 min) and the supernatants were collected to calculate the loading of every drug by fluorescence spectroscopy (Varioskan Flash from Thermo Scientific) and ultra performance liquid chromatography (Acquity).
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Drug release via NIR-illumination
One hundred µL of AuNG samples was placed in a 96-well transparent microplate and laser irradiation was carried out using a 808 nm fiber coupled laser diode with a maximum power of 4 W (Lumics). The spot size was chosen to iluminate the whole well at once (0.4 cm in diameter) and the power and time was adjusted to obtain the desired power density used for the experiments.
Co-culture and Live/Dead staining
Human dermal fibroblast (HDF; Invitrogen) cells were stained in suspension for 1 h, 37 °C, 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 Observer microscope with AxioVision software was used.
Flow cytometry
Human dermal fibroblast cells were stained in suspension for 1 h, 37 °C, using Cell Tracker Blue CMF2HC at a final dilution of 1/100 in FBS free DMEM. Cells were washed and mixed 1:1 with unstained HeLa cells and plated in a 24-well plate at 5x10 4 cells/well. The following day media was replaced with doxorubicin (4 µg/ml) and nanogel solutions (diluted 1/25, equivalent to 4 µg/ml doxorubicin), 500 µL/well. PEGMA nanogels were incubated with cells for 2h30, followed by washing with warmed PBS (10 mM, pH 7.4) and replacement of the media. The following day cells were lifted up using trypsin-EDTA and washed twice with ice-cold PBS. Samples were analysed in 1 % BSA/PBS on a BD Canto II flow cytometer using compensation. Cells were gated using the Pacific Blue channel (HeLa vs. CMF 2 HC-stained HDF cells), and then the % of doxorubicin positive cells measured in the PE channel.
Cell viability; irradiation experiments
HeLa cells were plated in a 96-well TC-treated transparent plate at 5x10 4 cells/mL, 100 µL/well. The following day media was replaced with doxorubicin (4 µg/mL) and NP solutions (diluted 1/25, equivalent to 4 µg/mL doxorubicin), 100 µL/well. NPs were left overnight with cells (approx 18 h) followed by replacement of the cell media. Individual wells were irradiated using a 808 nm fiber coupled laser diode with a maximum power of 4 W (Lumics). The spot size was chosen to illuminate the whole well at once (0.4 cm in diameter) and the power and time was adjusted to obtain the desired power density used for the experiments. The following day cell viability was analysed using the MTT assay (Roche) and absorbance measured at 550 nm, showing both non-irradiated and irradiated wells.
Transmission electron microscopy of cells
HeLa cells were grown in 60 mm diameter tissue culture treated petri dishes, 1x10 6 cells/3 mL/dish. The following day, nanogels were added at a final dilution of 1/50, 3 ml/dish. PEGMA nanogels were incubated with cells for 2 h, followed by washing with warm PBS and replacement of the medium. The day after, cells were fixed in the dish using 2 % formaldehyde/2.5 % glutaldehyde in Sorensens buffer (initial fixation of 10 min at rt, followed by secondary fixation with fresh solution for 2 h at 4°C). Fixative was removed and cells washed using cold Sorensens buffer. A cell scrapper was used to bring the cells into suspension. Cells were embedded in 2% agar, followed by further fixation and staining with a 1% osmodium tetraoxide solution for 1h on ice. Samples were washed with Sorensens buffer and then water, and dehydrated in an ethanol series, followed by 2 final pure ethanol and then pure acetone washes. Samples were embedded in Spurrs resin and polymerized overnight at 65 °C. One hundred nm slices were cut using an ultramicrotome and viewed using TEM (JEOL JEM-1400PLUS , 40kV -120kV). were removed and frozen for subsequent IL-6 analysis. Supernatants were analysed for IL-6 using standard sandwich ELISA with TMB substrate detection.
LPS-induced IL
Angiogenesis assays
Human umbilical vein endothelial cells (HUVEC) were plated in a normal tissue culture 96-well plate at 1x10 6 cells/ml, 100 µL/well. The following day nanogels were added at a final concentration equivalent to 10 µM pomalidomide. Cells were incubated with PEGMA nanogels for 2 h, followed by washing with warmed PBS and replacement of the media. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 Table of 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 
